Cargando…
Correction: PIK3CA mutation correlates with mTOR pathway expression but not clinical and pathological features in Fibro-adipose vascular anomaly (FAVA)
Autores principales: | Hori, Yumiko, Hirose, Katsutoshi, Ozeki, Michio, Hata, Kenji, Motooka, Daisuke, Tahara, Shinichiro, Matsui, Takahiro, Kohara, Masaharu, Higashihara, Hiroki, Ono, Yusuke, Tanaka, Kaishu, Toyosawa, Satoru, Morii, Eiichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063178/ https://www.ncbi.nlm.nih.gov/pubmed/35501918 http://dx.doi.org/10.1186/s13000-022-01224-5 |
Ejemplares similares
-
PIK3CA mutation correlates with mTOR pathway expression but not clinical and pathological features in Fibfibroipose vascular anomaly (FAVA)
por: Hori, Yumiko, et al.
Publicado: (2022) -
Fibro-adipose vascular anomaly (FAVA): three case reports with an emphasis on the mammalian target of rapamycin (mTOR) pathway
por: Hori, Yumiko, et al.
Publicado: (2020) -
Case Report of Fibro-Adipose Vascular Anomaly (FAVA) with Activating Somatic PIK3CA Mutation
por: Driskill, Jordan H., et al.
Publicado: (2022) -
Management of Fibro-adipose Vascular Anomalies (FAVA) in Paediatric Practice
por: Lipede, C, et al.
Publicado: (2021) -
Fibro-adipose vascular anomaly (FAVA) - diagnosis, staging and management
por: Wang, Huaijie, et al.
Publicado: (2023)